STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Corporate GovernanceApr 17, 2026, 08:46 AM

Forum Markets reinitiates buyback, forms special committee for value

AI Summary

Forum Markets, Inc. announced the reinitiation of its share repurchase program, effective April 15, 2026, with authorization for repurchases potentially exceeding Rule 10b-18 limitations. Concurrently, the Board established a Special Committee, comprised entirely of independent directors, to evaluate proposals aimed at maximizing shareholder value. The company also retained Clear Street LLC as its independent financial advisor to assist the Special Committee.

Key Highlights

  • Board reinitiated share repurchase program effective April 15, 2026.
  • Special Committee formed with independent directors to evaluate proposals for shareholder value.
  • Clear Street LLC retained as independent financial advisor to the Special Committee.
FRMM
Biotechnology: Pharmaceutical Preparations
FORUM MARKETS Inc

Price Impact